image
Acrivon Therapeutics, Inc. Common Stock ACRV
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.96
-12.1 %
$ 216 M
Market Cap
-2.56
P/E
BALANCE SHEET
138 M ASSETS
-23.71%
Growth Rates
1Year -23.71%
3Years 298.49%
5Years 0.00%
7Years 0.00%
10Years 0.00%
17.1 M LIABILITIES
58.78%
Growth Rates
1Year 58.78%
3Years 17.22%
5Years 0.00%
7Years 0.00%
10Years 0.00%
121 M EQUITY
-28.91%
Growth Rates
1Year -28.91%
3Years 154.10%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Acrivon Therapeutics, Inc. Common Stock
image
Current Assets 130 M
Cash & Short-Term Investments 127 M
Receivables 0
Other Current Assets 2.23 M
Non-Current Assets 8.57 M
Long-Term Investments 414 K
PP&E 7.91 M
Other Non-Current Assets 251 K
Current Liabilities 13.3 M
Accounts Payable 5.05 M
Short-Term Debt 1.75 M
Other Current Liabilities 6.5 M
Non-Current Liabilities 3.77 M
Long-Term Debt 3.77 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 36.0 29.5 99.6 1.6
Short Term Investments 91.4 98.2 0 0
Receivables 0 0 0 0
Inventory 0 0 0 0
Other Current Assets 2.2 4.3 0.8 0.1
Total Current Assets 129.7 127.8 100.4 1.7
PP&E 7.9 6.9 5.8 59 K
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0.4 41.9 0.4 0.4
Other Long Term Assets 0.3 4.7 0 0
Other Assets 1 0 0 0
Total Assets 138.3 181.2 106.6 2.2
LIABILITIES
Accounts Payable 5.0 0.9 1.0 0.1
Short Term Debt 1.8 1.5 0.7 58 K
Other Current Liabilities 6.5 4.1 1.2 0.4
Total Current Liabilities 13.3 6.5 2.9 0.6
Long Term Debt 3.8 4.2 5.0 0
Deferred Tax Income 0 0 0 0
Other Liabilities 0 0 122.5 0
Total Liabilities 17.1 10.8 130.4 10.6
EQUITY
Common Stock 23 K 22 K 2 K 1 K
Retained Earnings (116.4) (56.0) (24.9) (8.6)
Other Accumulative Comprehensive Income/Loss 83 K 95 K 0 0
Total Equity 121.2 170.5 (23.8) (8.4)
Total Liabilities and Equity 138.3 181.2 106.6 2.2
SHARES OUTSTANDING
Common Shares Outstanding 22.1 21.9 20.9 20.9